» Articles » PMID: 35939046

Polysome-CAGE of TCL1-driven Chronic Lymphocytic Leukemia Revealed Multiple N-terminally Altered Epigenetic Regulators and a Translation Stress Signature

Overview
Journal Elife
Specialty Biology
Date 2022 Aug 8
PMID 35939046
Authors
Affiliations
Soon will be listed here.
Abstract

The transformation of normal to malignant cells is accompanied by substantial changes in gene expression programs through diverse mechanisms. Here, we examined the changes in the landscape of transcription start sites and alternative promoter (AP) usage and their impact on the translatome in TCL1-driven chronic lymphocytic leukemia (CLL). Our findings revealed a marked elevation of APs in CLL B cells from Eµ-Tcl1 transgenic mice, which are particularly enriched with intra-genic promoters that generate N-terminally truncated or modified proteins. Intra-genic promoter activation is mediated by (1) loss of function of 'closed chromatin' epigenetic regulators due to the generation of inactive N-terminally modified isoforms or reduced expression; (2) upregulation of transcription factors, including , targeting the intra-genic promoters and their associated enhancers. Exogenous expression of in MEFs is sufficient to induce intra-genic promoters of epigenetic regulators and promote expression. We further found a dramatic translation downregulation of transcripts bearing CNY cap-proximal trinucleotides, reminiscent of cells undergoing metabolic stress. These findings uncovered the role of oncogenic function in altering promoter usage and mRNA translation in leukemogenesis.

Citing Articles

Polysome-CAGE of TCL1-driven chronic lymphocytic leukemia revealed multiple N-terminally altered epigenetic regulators and a translation stress signature.

Ogran A, Havkin-Solomon T, Becker-Herman S, David K, Shachar I, Dikstein R Elife. 2022; 11.

PMID: 35939046 PMC: 9359700. DOI: 10.7554/eLife.77714.

References
1.
Forrest A, Kawaji H, Rehli M, Baillie J, de Hoon M, Haberle V . A promoter-level mammalian expression atlas. Nature. 2014; 507(7493):462-70. PMC: 4529748. DOI: 10.1038/nature13182. View

2.
Thodberg M, Sandelin A . A step-by-step guide to analyzing CAGE data using R/Bioconductor. F1000Res. 2019; 8:886. PMC: 6613478. DOI: 10.12688/f1000research.18456.1. View

3.
Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M . An atlas of active enhancers across human cell types and tissues. Nature. 2014; 507(7493):455-461. PMC: 5215096. DOI: 10.1038/nature12787. View

4.
Fornes O, Castro-Mondragon J, Khan A, van der Lee R, Zhang X, Richmond P . JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2019; 48(D1):D87-D92. PMC: 7145627. DOI: 10.1093/nar/gkz1001. View

5.
Herling M, Patel K, Teitell M, Konopleva M, Ravandi F, Kobayashi R . High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood. 2007; 111(1):328-37. PMC: 2200815. DOI: 10.1182/blood-2007-07-101519. View